Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
What conditions must be ruled out for someone to be diagnosed with hEDS or HSD
Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition
It is specifically formulated for multi-use peptide reconstitution and is the correct solvent for the majority of lyophilised research peptides including GH secretagogues, GHRH analogues, GLP-1 receptor agonists, lipolytic fragments, and neuropeptides supplied by EU peptide research suppliers
Composition BPC-157: 10 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Choline and methionine, both found in B complex injections, are considered lipotropic agents, meaning they help the liver process and remove fats
